Search

Your search keyword '"Asunción Hervás"' showing total 102 results

Search Constraints

Start Over You searched for: Author "Asunción Hervás" Remove constraint Author: "Asunción Hervás"
102 results on '"Asunción Hervás"'

Search Results

1. Mortality and biochemical recurrence after surgery, brachytherapy, or external radiotherapy for localized prostate cancer: a 10-year follow-up cohort study

2. Health-related quality of life in men with localized prostate cancer treated with radiotherapy: validation of an abbreviated version of the Expanded Prostate Cancer Index Composite for Clinical Practice in Spain

3. Phase II Study of ENZAlutamide Combined With Hypofractionated Radiation Therapy (ENZART) for Localized Intermediate Risk Prostate Cancer

4. Predictive factors for tumour response after the neoadjuvant-treatment of rectal adenocarcinoma

5. Magnetic Resonance Imaging Value to Predict Pathologic Staging in Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation

6. La oncología radioterápica moderna: situación actual

7. 243: Evaluation of EMBARK criteria patients. Real-world data on prostate cancer biochemical recurrence.

8. Assessing radiation dose for postoperative radiotherapy in prostate cancer: Real world data

9. The use of a thin guide‐wire for urethral definition in prostate SBRT treatments with Cyberknife

10. Health-related quality of life in men with localized prostate cancer treated with radiotherapy: validation of an abbreviated version of the Expanded Prostate Cancer Index Composite for Clinical Practice in Spain

11. Is hypofractionation acceptable for prostate bed radiotherapy?

12. Interobserver variability in gross tumor volume contouring in non-spine bone metastases

13. SARS CoV-2 virus in cancer patients: a new unknown in an unsolved equation

14. Treatment Landscape of Nonmetastatic Castration-Resistant Prostate Cancer: A Window of Opportunity

15. Salvage brachytherapy for locally-recurrent prostate cancer after radiation therapy: A comparison of efficacy and toxicity outcomes with high-dose rate and low-dose rate brachytherapy

16. Magnetic Resonance Imaging Value to Predict Pathologic Staging in Locally Advanced Rectal Cancer After Neoadjuvant Chemoradiation

17. Phase I Trial of Cemiplimab, Radiotherapy, Cyclophosphamide, and Granulocyte Macrophage Colony‐Stimulating Factor in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

18. Radiotherapy impact on health-related quality of life in localized prostate cancer: results of an observational, non-interventional, multicenter study in Spain

19. PD-0913 Local treatment to the primary tumor and PSA changes as prognostic factors in mCRPC

20. Comparative Effectiveness Research in Localized Prostate Cancer: A 10-Year Follow-up Cohort Study

21. Predictive factors for tumour response after the neoadjuvant-treatment of rectal adenocarcinoma

22. Watch and wait approach in rectal cancer: Current controversies and future directions

23. Radiotherapy impact on health-related quality of life in localized prostate cancer: results of an observational, non-interventional, multicenter study in Spain

24. Phase II Trial of SBRT and Androgen Deprivation for Oligometastases in Prostate Cancer

25. Adjuvant versus salvage radiotherapy in prostate cancer: multi-institutional retrospective analysis of the Spanish RECAP database

26. PO-1168: Radiotherapy in high risk prostate cancer: Whole pelvic radiotherapy vs prostate only radiotherapy

27. PD-0534: Dose-escalation phase III trial of preoperative chemoradiotherapy in rectal cancer. First results

28. Outcomes and prognostic factors in intermediate-risk prostate cancer: multi-institutional analysis of the Spanish RECAP database

29. Phase II Trial of SBRT and Hormone Therapy for Oligometastases in Prostate Cancer

30. Three linked nomograms for predicting biochemical failure in prostate cancer treated with radiotherapy plus androgen deprivation therapy

31. Salvage Brachytherapy in Prostate Cancer after Radiation Failure: HDR vs LDR

32. EP-1443: Dose-escalated radiation therapy for neoadjuvant chemoradiotherapy in oesophagueal cancer

33. Quality of life impact of treatments for localized prostate cancer: Cohort study with a 5year follow-up

34. Incidence of human papillomavirus-related oropharyngeal cancer and outcomes after chemoradiation in a population of heavy smokers

35. Nasopharyngeal mucoepidermoid carcinoma: A case report and review of literature

36. Intermittent versus continuous androgen deprivation therapy to biochemical recurrence after external beam radiotherapy: a phase 3 GICOR study

37. EP-1284: Predictive factors of tumour response after neoadjuvant chemoradiation for rectal cancer

38. OC-0175: Salvage HDR-BT in prostate local recurrence after radiation therapy: Retrospective analysis

39. Quality-of-Life Impact of Primary Treatments for Localized Prostate Cancer in Patients Without Hormonal Treatment

41. EP-1652: Moderately hypofractionated radiotherapy for unresectable esophagus-gastric carcinoma

42. High-dose-rate (HDR) plesiotherapy with custom-made moulds for the treatment of non-melanoma skin cancer

43. Late gastrointestinal complications after pelvic radiotherapy: radiation enteritis

44. Evaluación de la calidad de vida de los pacientes con cáncer de próstata localizado: validación de la versión española del cuestionario EPIC

45. Corrigendum to 'Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance'. [Rep. Pract. Oncol. Radiother. 20 (2015) 259-272]

46. The number of risk factors is the strongest predictor of prostate cancer mortality: multi-institutional outcomes of an extreme-risk prostate cancer cohort

47. Spine Instability Neoplastic Score: agreement across different medical and surgical specialties

48. Agreement in the assessment of metastatic spine disease using scoring systems

49. Treatment of localised prostate cancer with radiation therapy: evidence versus opinion

Catalog

Books, media, physical & digital resources